AAAAAA

   
Results: 1-25 | 26-42
Results: 1-25/42
STAGE-I AND STAGE-II ENDOMETRIAL CARCINOMA - PROGNOSTIC FACTORS AND SURGICAL IMPLICATIONS
Authors: MICHEL G MORICE P CASTAIGNE D LANOUX P PAUTIER P LHOMME C GERBAULET A DUVILLARD P
Citation: G. Michel et al., STAGE-I AND STAGE-II ENDOMETRIAL CARCINOMA - PROGNOSTIC FACTORS AND SURGICAL IMPLICATIONS, Contraception fertilite sexualite, 26(6), 1998, pp. 452-456
ISOLATED LEPTOMENINGEAL METASTASIS FROM OVARIAN-CARCINOMA - AN UNUSUAL EVENT
Authors: DELORD JP FIZAZI K ELHAJJ M PAUTIER P LHOMME C
Citation: Jp. Delord et al., ISOLATED LEPTOMENINGEAL METASTASIS FROM OVARIAN-CARCINOMA - AN UNUSUAL EVENT, European journal of cancer, 34(5), 1998, pp. 758-759
CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/
Authors: HERON JF JOLY F KERBRAT P CHAUVERGNE J MAYER F WEBER B CHINETCHARROT P CROUET H GOUPIL A LESECH JM LEBRUNJEZEKOVA D NAMER M MARTIN C GUASTALLA JP LHOMME C
Citation: Jf. Heron et al., CISPLATIN CARBOPLATIN/CYCLOPHOSPHAMIDE (CCP) VS CISPLATIN/CYCLOPHOSPHAMIDE (CP) IN STAGE III-IV EPITHELIAL OVARIAN-CANCER - A FRENCH RANDOMIZED PHASE-III STUDY/, Annals of oncology, 9, 1998, pp. 315-315
NEUROENDOCRINE SMALL-CELL CARCINOMA OF THE CERVIX - A RARE, AGGRESSIVE, AND CHEMORESISTANT DISEASE
Authors: DELALOGE S GOCALVEZ E PAUTIER P DUVILLARD P HAIEMEDER C GOUPIL A MICHEL G LHOMME C
Citation: S. Delaloge et al., NEUROENDOCRINE SMALL-CELL CARCINOMA OF THE CERVIX - A RARE, AGGRESSIVE, AND CHEMORESISTANT DISEASE, Annals of oncology, 9, 1998, pp. 341-341
FEASIBILITY TRIAL OF PACLITAXEL (PXL), OXALIPLATIN (L-OHP) AND CISPLATIN (CDDP) COMBINATION IN ADVANCED OVARIAN-CANCER PATIENTS
Authors: CHOUAKI N TAAMMA A LADEM A DELALOGE S MISSET JL PAUTIER P LHOMME C CVITKOVIC E
Citation: N. Chouaki et al., FEASIBILITY TRIAL OF PACLITAXEL (PXL), OXALIPLATIN (L-OHP) AND CISPLATIN (CDDP) COMBINATION IN ADVANCED OVARIAN-CANCER PATIENTS, Annals of oncology, 9, 1998, pp. 346-346
SERUM LEVELS OF DIMERIC ACTIVIN A ARE NOT A MARKER OF PLACENTAL TUMORS IN THE COURSE OF CHEMOTHERAPY
Authors: FLORIO P LUISI S CASAROSA E GENAZZANI AR PAUTIER P LHOMME C BIDART JM DRIUL PG PETRAGLIA F
Citation: P. Florio et al., SERUM LEVELS OF DIMERIC ACTIVIN A ARE NOT A MARKER OF PLACENTAL TUMORS IN THE COURSE OF CHEMOTHERAPY, Journal of endocrinological investigation, 21(3), 1998, pp. 166-169
INHIBIN-B IS THE MAJOR FORM OF INHIBIN ACTIVIN FAMILY SECRETED BY GRANULOSA-CELL TUMORS/
Authors: PETRAGLIA F LUISI S PAUTIER P SABOURIN JC REY R LHOMME C BIDART JM
Citation: F. Petraglia et al., INHIBIN-B IS THE MAJOR FORM OF INHIBIN ACTIVIN FAMILY SECRETED BY GRANULOSA-CELL TUMORS/, The Journal of clinical endocrinology and metabolism, 83(3), 1998, pp. 1029-1032
ADULT GRANULOSA-CELL TUMOR OF THE OVARY - A RETROSPECTIVE STUDY OF 45CASES
Authors: PAUTIER P LHOMME C CULINE S DUVILLARD P MICHEL G BIDART JM GERBAULET A DROZ JP
Citation: P. Pautier et al., ADULT GRANULOSA-CELL TUMOR OF THE OVARY - A RETROSPECTIVE STUDY OF 45CASES, International journal of gynecological cancer, 7(1), 1997, pp. 58-65
INACTIVATION OF BOTH ALLELES OF BRCA1 COU LD BE OF GOOD PROGNOSIS IN OVARY ADENOCARCINOMA
Authors: JANIN N LE M LHOMME C
Citation: N. Janin et al., INACTIVATION OF BOTH ALLELES OF BRCA1 COU LD BE OF GOOD PROGNOSIS IN OVARY ADENOCARCINOMA, MS. Medecine sciences, 13(4), 1997, pp. 591-592
EXTENSIVE CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN-CARCINOMA
Authors: MICHEL G DEIACO P CASTAIGNE D ELHASSAN MJ LOBREGLIO R LHOMME C REY A DUVILLARD P
Citation: G. Michel et al., EXTENSIVE CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN-CARCINOMA, European journal of gynaecological oncology, 18(1), 1997, pp. 9-15
CISPLATIN-BASED CHEMOTHERAPY IN THE MANAGEMENT OF GERM-CELL TUMORS OFTHE OVARY - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE
Authors: CULINE S LHOMME C KATTAN J MICHEL G DUVILLARD P DROZ JP
Citation: S. Culine et al., CISPLATIN-BASED CHEMOTHERAPY IN THE MANAGEMENT OF GERM-CELL TUMORS OFTHE OVARY - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE, Gynecologic oncology, 64(1), 1997, pp. 160-165
DIFFERENTIATION BETWEEN RECURRENT TUMOR AND BENIGN CONDITIONS AFTER TREATMENT OF GYNECOLOGIC PELVIC CARCINOMA - VALUE OF DYNAMIC CONTRAST-ENHANCED SUBTRACTION MR-IMAGING
Authors: KINKEL K ARICHE M TARDIVON AA SPATZ A CASTAIGNE D LHOMME C VANEL D
Citation: K. Kinkel et al., DIFFERENTIATION BETWEEN RECURRENT TUMOR AND BENIGN CONDITIONS AFTER TREATMENT OF GYNECOLOGIC PELVIC CARCINOMA - VALUE OF DYNAMIC CONTRAST-ENHANCED SUBTRACTION MR-IMAGING, Radiology, 204(1), 1997, pp. 55-63
MEDICAL-TREATMENT OF OVARIAN GERM-CELL MALIGNANCIES IN THE ADULT
Authors: CULINE S LHOMME C DROZ JP
Citation: S. Culine et al., MEDICAL-TREATMENT OF OVARIAN GERM-CELL MALIGNANCIES IN THE ADULT, Bulletin du cancer, 84(9), 1997, pp. 919-921
NEGATIVE 2ND-LOOK LAPAROTOMY - AN OVARIAN -CANCER ANALYSIS OF PROGNOSTIC AND SURVIVAL FACTORS BASED ON 64 CASES TREATED AT THE INSTITUT GUSTAVE-ROUSSY
Authors: PAUTIER P REY A MICHEL G CASTAIGNE D ROCHARD F DUVILLARD P HAIEMEDER C CURCIO P BENEDETTIRICHARD L LHOMME C
Citation: P. Pautier et al., NEGATIVE 2ND-LOOK LAPAROTOMY - AN OVARIAN -CANCER ANALYSIS OF PROGNOSTIC AND SURVIVAL FACTORS BASED ON 64 CASES TREATED AT THE INSTITUT GUSTAVE-ROUSSY, Bulletin du cancer, 84(2), 1997, pp. 147-154
ARE THERE ANY ARGUMENTS TO PROSCRIBE HORM ONE REPLACEMENT THERAPY IN WOMEN TREATED FOR OVARIAN ADENOCARCINOMA
Authors: LHOMME C DELALOGE S GONCALVES E TALEA V PAUTIER P
Citation: C. Lhomme et al., ARE THERE ANY ARGUMENTS TO PROSCRIBE HORM ONE REPLACEMENT THERAPY IN WOMEN TREATED FOR OVARIAN ADENOCARCINOMA, Bulletin du cancer, 84(10), 1997, pp. 981-986
ACTIVATED PROTEIN-C RESISTANCE IS RARELY ASSOCIATED WITH THROMBOTIC EVENTS IN PATIENTS WITH OVARIAN-CANCER
Authors: SALABELLE A RIBRAG V NASR F PAUTIER P CORTI C ELHAJJ M LHOMME C BAYLE C BENNACEURGRISCELLI A
Citation: A. Salabelle et al., ACTIVATED PROTEIN-C RESISTANCE IS RARELY ASSOCIATED WITH THROMBOTIC EVENTS IN PATIENTS WITH OVARIAN-CANCER, Blood, 90(10), 1997, pp. 3261-3261
INTRAVAGINAL AMPUTATION OF THE UTERINE CERVIX WITH FROZEN-SECTION EXAMINATION OF THE ENDOCERVICAL MARGIN - A REVIEW OF 414 CONSECUTIVE PATIENTS
Authors: BIENVENU L SPATZ A DUVILLARD P CASTAIGNE D ROCHARD F LHOMME C LARTIGAU E MAHFOUD N MICHEL G PRADE M
Citation: L. Bienvenu et al., INTRAVAGINAL AMPUTATION OF THE UTERINE CERVIX WITH FROZEN-SECTION EXAMINATION OF THE ENDOCERVICAL MARGIN - A REVIEW OF 414 CONSECUTIVE PATIENTS, International journal of gynecological cancer, 6(6), 1996, pp. 452-455
CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY
Authors: LHOMME C KERBRAT P LEJEUNE C GUASTALLA JP FUMOLEAU P GOUPIL A HERON JF CASSIN MA PRUVOT I SOARES JA CHAZARD M
Citation: C. Lhomme et al., CARBOPLATIN PLUS PACLITAXEL IN THE FIRST-LINE TREATMENT OF ADVANCED OVARIAN-CANCER - PRELIMINARY-RESULTS OF A PHASE-I STUDY, Seminars in oncology, 23(5), 1996, pp. 48-54
EQUINE DYSAUTONOMIA - AN ANATOMOCLINICAL STUDY OF 8 CASES
Authors: LHOMME C COLLOBERTLAUGIER C AMARDEILH MF DELVERDIER M
Citation: C. Lhomme et al., EQUINE DYSAUTONOMIA - AN ANATOMOCLINICAL STUDY OF 8 CASES, Revue de Medecine Veterinaire, 147(11), 1996, pp. 805
IS THERE A ROLE FOR 2ND-LOOK LAPAROTOMY IN THE MANAGEMENT OF MALIGNANT GERM-CELL TUMORS OF THE OVARY - EXPERIENCE AT INSTITUT-GUSTAVE-ROUSSY
Authors: CULINE S LHOMME C MICHEL G LECLERE J DUVILLARD P DROZ JP
Citation: S. Culine et al., IS THERE A ROLE FOR 2ND-LOOK LAPAROTOMY IN THE MANAGEMENT OF MALIGNANT GERM-CELL TUMORS OF THE OVARY - EXPERIENCE AT INSTITUT-GUSTAVE-ROUSSY, Journal of surgical oncology, 62(1), 1996, pp. 40-45
DESMOPLASTIC SMALL ROUND-CELL TUMORS - RESULTS OF A 4-DRUG CHEMOTHERAPY REGIMEN IN 5 ADULT PATIENTS
Authors: FARHAT F CULINE S LHOMME C DUVILLARD P SOULIE P MICHEL G TERRIERLACOMBE MJ THEODORE C SCHREINEROVA M DROZ JP
Citation: F. Farhat et al., DESMOPLASTIC SMALL ROUND-CELL TUMORS - RESULTS OF A 4-DRUG CHEMOTHERAPY REGIMEN IN 5 ADULT PATIENTS, Cancer, 77(7), 1996, pp. 1363-1366
IS THERE A PLACE FOR CHEMOTHERAPY IN THE INITIAL TREATMENT FOR CERVICAL-CANCER - LITERATURE-REVIEW
Authors: LHOMME C SCHREINEROVA M DELORME T MURAWADURAND S CHAZARD M
Citation: C. Lhomme et al., IS THERE A PLACE FOR CHEMOTHERAPY IN THE INITIAL TREATMENT FOR CERVICAL-CANCER - LITERATURE-REVIEW, Bulletin du cancer, 83(4), 1996, pp. 276-292
ANTIMULLERIAN HORMONE AS A SERUM MARKER OF GRANULOSA-CELL TUMORS OF THE OVARY - COMPARATIVE-STUDY WITH SERUM ALPHA-INHIBIN AND ESTRADIOL
Authors: REY RA LHOMME C MARCILLAC I LAHLOU N DUVILLARD P JOSSO N BIDART JM
Citation: Ra. Rey et al., ANTIMULLERIAN HORMONE AS A SERUM MARKER OF GRANULOSA-CELL TUMORS OF THE OVARY - COMPARATIVE-STUDY WITH SERUM ALPHA-INHIBIN AND ESTRADIOL, American journal of obstetrics and gynecology, 174(3), 1996, pp. 958-965
PURE MALIGNANT IMMATURE TERATOMA OF THE OVARY - THE ROLE OF CHEMOTHERAPY AND 2ND-LOOK SURGERY
Authors: CULINE S LHOMME C KATTAN J MICHEL G DUVILLARD P DROZ JP
Citation: S. Culine et al., PURE MALIGNANT IMMATURE TERATOMA OF THE OVARY - THE ROLE OF CHEMOTHERAPY AND 2ND-LOOK SURGERY, International journal of gynecological cancer, 5(6), 1995, pp. 432-437
HIGH-DOSE CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH BULKY RESIDUAL DISEASE
Authors: HERON JF LHOMME C KERBRAT P MAYER F CHEVALLIER B GOUPIL A VENNIN P LEBRUN D CHAUVERGNE J AYME Y NAMER M
Citation: Jf. Heron et al., HIGH-DOSE CHEMOTHERAPY IN ADVANCED OVARIAN-CARCINOMA WITH BULKY RESIDUAL DISEASE, European journal of cancer, 31A, 1995, pp. 503-503
Risultati: 1-25 | 26-42